Ductal Carcinoma in situ (DCIS) (USA)

47 year old lady asymptomatic. Screening. Very dense breasts, deep water and conventional mammograms we could detect. A group of microcalcifications in the right breast. Which almost synthesis do also detect the microcalcifications. And. It's a similar. To the to the view. However. Magnification views are very nice because you see and you can characterize these microcalcifications as you know morphic microcalcifications and of course a biopsy is needed. The final result was this year, yes. So in my experience. Magnification views are still necessary for the evaluation of microcalcifications.

3:37 Screening 5 Digital Breast Tomosynthesis and Contrast Enhanced Mammography Prof. Dr. Luis Pina Breast Imaging Department (Radiología mamaria) Clínica Universidad de Navarra, Pamplona / Spain SIEMENS . 04_Screening_5, PID3694 * 1/1/2022 F PID3694 TRMLO Series Navigator INSIGHT_2D Add Study PID3694 2/1/2022 (Study date) Current INSIGHT 2D_RCC TRCC TLCC MG, 2/1/2022 n.a ., 2 mont ... MAMOGRAFIA TOMO Viewing Favorite Layouts MR DYN MR.Dyna ... ReportFlow MR.Empty BASI Printing Tools Findings MR 3:36 PM US Clinical information 47-year-old female Asymptomatic BASIC C.US | C .... Healthineers RCC LCC 2/8/2022, 3:17:12 PM 2/8/2022. 3:18:30 PM 2/8/2022, 3:16:01 PM Current Current Slice 23 / 41 Slice 9 / 39 Slice 22 / 40 Slice 16 / 44 Slice thickness: 1.00 mm LCC RMLO Slice 16/ 44 Slice 26 / 41 Slice 16/ 44 Slice 24 / 41 RMLO 2/8/2022, 3:14:58 PM Slice 21 / 40 RMSML RMSCC C.CC Pathology Ductal carcinoma in situ (DCIS) Conclusion Although DBT is useful to evaluate microcalcifications, magnification views are still necessary. Siemens Healthcare GmbH, 2022 Sometimes IN2D images (= synthetic mammograms) are shown while verbally referring to the conventional mammograms. The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed. Results from case studies are not predictive of results in other cases. Results in other cases may vary. The statements by Siemens' customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" setting and many variables exist (e.g ., hospital size, samples mix, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results. Dr. Luis Pina is employed by an institution that receives financial support from Siemens Healthineers for collaborations. SIEMENS